2961 related articles for article (PubMed ID: 12912744)
1. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
[TBL] [Abstract][Full Text] [Related]
2. Resection of pancreatic neuroendocrine tumors: results of 70 cases.
Kazanjian KK; Reber HA; Hines OJ
Arch Surg; 2006 Aug; 141(8):765-9; discussion 769-70. PubMed ID: 16924083
[TBL] [Abstract][Full Text] [Related]
3. Aggressive pancreatic resection for primary pancreatic neuroendocrine tumor: is it justifiable?
Teh SH; Deveney C; Sheppard BC
Am J Surg; 2007 May; 193(5):610-3; discussion 613. PubMed ID: 17434366
[TBL] [Abstract][Full Text] [Related]
4. [Operative management and long-term survival in patients with neuroendocrine tumors of the pancreas--experience with 144 patients].
Fendrich V; Habbe N; Celik I; Langer P; Zielke A; Bartsch DK; Rothmund M
Dtsch Med Wochenschr; 2007 Feb; 132(5):195-200. PubMed ID: 17252361
[TBL] [Abstract][Full Text] [Related]
5. Surgical experience with nonfunctioning neuroendocrine tumors of the pancreas.
Matthews BD; Heniford BT; Reardon PR; Brunicardi FC; Greene FL
Am Surg; 2000 Dec; 66(12):1116-22; discussion 1122-3. PubMed ID: 11149582
[TBL] [Abstract][Full Text] [Related]
6. Long-term results of a selective surgical approach to management of Zollinger-Ellison syndrome in patients with MEN-1.
Mortellaro VE; Hochwald SN; McGuigan JE; Copeland EM; Vogel SB; Grobmyer SR
Am Surg; 2009 Aug; 75(8):730-3. PubMed ID: 19725300
[TBL] [Abstract][Full Text] [Related]
7. En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients.
Yekebas EF; Bogoevski D; Cataldegirmen G; Kunze C; Marx A; Vashist YK; Schurr PG; Liebl L; Thieltges S; Gawad KA; Schneider C; Izbicki JR
Ann Surg; 2008 Feb; 247(2):300-9. PubMed ID: 18216537
[TBL] [Abstract][Full Text] [Related]
8. Aggressive multi-visceral pancreatic resections for locally advanced neuroendocrine tumours. Is it worth it?
Abu Hilal M; McPhail MJ; Zeidan BA; Jones CE; Johnson CD; Pearce NW
JOP; 2009 May; 10(3):276-9. PubMed ID: 19454819
[TBL] [Abstract][Full Text] [Related]
9. [Surgical therapy of gastrinoma with associated Zollinger-Ellison syndrome].
Schröder W; Hölscher AH; Beckurts KT; Schusdziarra V; Höfler H; Siewert JR
Z Gastroenterol; 1996 Aug; 34(8):465-72. PubMed ID: 8967120
[TBL] [Abstract][Full Text] [Related]
10. Pancreatectomy combined with superior mesenteric-portal vein resection: report of 32 cases.
Zhou GW; Wu WD; Xiao WD; Li HW; Peng CH
Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):130-4. PubMed ID: 15730937
[TBL] [Abstract][Full Text] [Related]
11. Surgical strategies and predictors of outcome for malignant neuroendocrine tumors of the pancreas.
Bahra M; Jacob D; Pascher A; Plockinger U; Kristiansen G; Neuhaus P; Langrehr JM
J Gastroenterol Hepatol; 2007 Jun; 22(6):930-5. PubMed ID: 17489964
[TBL] [Abstract][Full Text] [Related]
12. Surgery to cure the Zollinger-Ellison syndrome.
Norton JA; Fraker DL; Alexander HR; Venzon DJ; Doppman JL; Serrano J; Goebel SU; Peghini PL; Roy PK; Gibril F; Jensen RT
N Engl J Med; 1999 Aug; 341(9):635-44. PubMed ID: 10460814
[TBL] [Abstract][Full Text] [Related]
13. Extended lymphadenectomy and vein resection for pancreatic head cancer: outcomes and implications for therapy.
Capussotti L; Massucco P; Ribero D; Viganò L; Muratore A; Calgaro M
Arch Surg; 2003 Dec; 138(12):1316-22. PubMed ID: 14662531
[TBL] [Abstract][Full Text] [Related]
14. Central pancreatectomy: single-center experience of 50 cases.
Adham M; Giunippero A; Hervieu V; Courbière M; Partensky C
Arch Surg; 2008 Feb; 143(2):175-80; discussion 180-1. PubMed ID: 18283143
[TBL] [Abstract][Full Text] [Related]
15. Carcinoma of the pancreas: resection outcome at the University Hospital Kuala Lumpur.
Shahrudin MD
Int Surg; 1997; 82(3):269-74. PubMed ID: 9372373
[TBL] [Abstract][Full Text] [Related]
16. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
Ridwelski K; Meyer F; Schmidt U; Lippert H
Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
[TBL] [Abstract][Full Text] [Related]
17. Significance of lymph node metastases in the surgical management of pancreatic head carcinoma.
Benassai G; Mastrorilli M; Mosella F; Mosella G
J Exp Clin Cancer Res; 1999 Mar; 18(1):23-8. PubMed ID: 10374672
[TBL] [Abstract][Full Text] [Related]
18. Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: review of 125 patients.
Phan GQ; Yeo CJ; Hruban RH; Lillemoe KD; Pitt HA; Cameron JL
J Gastrointest Surg; 1998; 2(5):472-82. PubMed ID: 9843608
[TBL] [Abstract][Full Text] [Related]
19. [Pancreatic endocrine tumors].
Târcoveanu E; Moldovanu R; Georgescu S; Niculescu D; Lupaşcu C; Dimofte G
Chirurgia (Bucur); 2006; 101(2):175-81. PubMed ID: 16752684
[TBL] [Abstract][Full Text] [Related]
20. Pancreaticoduodenectomy for islet cell tumors of the head of the pancreas: long-term survival analysis.
Sarmiento JM; Farnell MB; Que FG; Nagorney DM
World J Surg; 2002 Oct; 26(10):1267-71. PubMed ID: 12205558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
